间(2-甲基-4-氯苯基)苯甲酸 | 916220-05-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 间(2-甲基-4-氯苯基)苯甲酸
• 中文别名: 4-氯-2-甲基-[1,1-联苯]-3-羧酸
• 英文名称: 4'-chloro-2'-methyl-biphenyl-3-carboxylic acid
• 英文别名: 4'-chloro-2'-methylbiphenyl-3-carboxylic acid；3-(4-Chloro-2-methylphenyl)benzoic acid
• CAS: 916220-05-8
• 化学式: C₁₄H₁₁ClO₂
• 分子量: 246.693
• InChiKey: DFYRPLGXXFUTLB-UHFFFAOYSA-N

物化性质

• 沸点：
  410.0±33.0 °C(Predicted)
• 密度：
  1.262

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2916399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-(4-Chloro-2-methylphenyl)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-(4-Chloro-2-methylphenyl)benzoic acid
CAS number: 916220-05-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C14H11ClO2
Molecular weight: 246.7

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  间(2-甲基-4-氯苯基)苯甲酸 在 lithium aluminium tetrahydride 、 氯化亚砜 、 水 、 caesium carbonate 、 sodium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 22.0h， 生成 (S)-3-[4-(4'-chloro-2'-methylbiphenyl-3-ylmethoxy)phenyl]-3-(1-methyl-1H-tetrazol-5-yl)propionic acid
  参考文献：
  名称：

  Optimization of GPR40 Agonists for Type 2 Diabetes

  摘要：

  GPR40 (FFA1 and FFAR1) has gained significant interest as a target for the treatment of type 2 diabetes. TAK-875 (1), a GPR40 agonist, lowered hemoglobin A1c (HbA1c) and lowered both postprandial and fasting blood glucose levels in type 2 diabetic patients in phase II clinical trials. We optimized phenylpropanoic acid derivatives as GPR40 agonists and identified AMG 837 (2) as a clinical candidate. Here we report our efforts in searching for structurally distinct back-ups for AMG 837. These efforts led to the identification of more polar GPR40 agonists, such as AM-4668 (10), that have improved potency, excellent pharmacokinetic properties across species, and minimum central nervous system (CNS) penetration.

  DOI：

  10.1021/ml400501x
• 作为产物：
  描述：

  4-氯-2-甲基苯硼酸 、 3-碘苯甲酸 在 palladium 10% on activated carbon sodium carbonate 、 盐酸 作用下， 以 水 、 异丙醇 为溶剂， 生成 间(2-甲基-4-氯苯基)苯甲酸
  参考文献：
  名称：

  Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders

  摘要：

  本发明提供了一种化合物，例如，用于调节受试者体内胰岛素水平，其具有一般式I： 其中Q是可选择取代的苯基；L是键或O；P是苯环或可选择取代的噻唑环；R1具有此处提供的值。本发明还提供了所述化合物的组合物、用途和使用方法，例如，用于治疗2型糖尿病。

  公开号：

  US20060270724A1

文献信息

• Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
  申请人：Houze Jonathan

  公开号：US20060270724A1

  公开（公告）日：2006-11-30

  The present invention provides compounds useful, for example, for modulating insulin levels in a subject, having the general formula I: wherein Q is an optionally substituted phenyl; L is a bond or O; P is a benzene or an optionally substituted thiazole ring; and R 1 has the values provided herein. The present invention also provides compositions, uses, and methods for use of the compounds, for instance, for treatment of type II diabetes.

  本发明提供了一种化合物，例如，用于调节受试者体内胰岛素水平，其具有一般式I： 其中Q是可选择取代的苯基；L是键或O；P是苯环或可选择取代的噻唑环；R1具有此处提供的值。本发明还提供了所述化合物的组合物、用途和使用方法，例如，用于治疗2型糖尿病。
• The 1,3-Diaminobenzene-Derived Aminophosphine Palladium Pincer Complex {C6H3[NHP(piperidinyl)2]2Pd(Cl)} - A Highly Active Suzuki-Miyaura Catalyst with Excellent Functional Group Tolerance
  作者：Jeanne L. Bolliger、Christian M. Frech

  DOI：10.1002/adsc.200900848

  日期：——

  The rapidly prepared 1,3‐diaminobenzene‐derived aminophosphine pincer complex C6H3[NHP(piperidinyl)2]2Pd(Cl)} (1) is an effective Suzuki catalyst with excellent functional group tolerance. Side‐product formations, such as homocoupling, debromation or protodeboration have only rarely been detected and if so, were in all cases below the 5% level. The presented reaction protocol is universally applicable

  快速制备的1,3-二氨基苯衍生的氨基膦钳形配合物C 6 H 3 [NHP（哌啶基）2 ] 2 Pd（Cl）}（1）是一种有效的Suzuki催化剂，具有出色的官能团耐受性。仅很少检测到副产物形成，例如均偶联，去溴化或原去硼，如果这样，在所有情况下均低于5％的水平。提出的反应方案是普遍适用的。实验观察表明，钯纳米颗粒的催化活性形式1。
• Compounds, their pharmaceutical compositions and their use in treating metabolic disorders
  申请人：Amgen, Inc

  公开号：EP1893582B1

  公开（公告）日：2011-12-14
• COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE IN TREATING METABOLIC DISORDERS
  申请人：Amgen, Inc

  公开号：EP1893582A2

  公开（公告）日：2008-03-05
• US7465804B2
  申请人：——

  公开号：US7465804B2

  公开（公告）日：2008-12-16